Healthcare stocks were advancing premarket Thursday, with the State Street Health Care Select Sector SPDR ETF (XLV) up 0.2% and the iShares Biotechnology ETF (IBB) 0.5% higher.
Denali Therapeutics (DNLI) stock was up 1.8% after the company said it has signed an agreement to sell its rare pediatric disease priority review voucher for gross proceeds of $195 million.